These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 20117176)

  • 1. Selection of optimal passage of bone marrow-derived mesenchymal stem cells for stem cell therapy in patients with amyotrophic lateral sclerosis.
    Choi MR; Kim HY; Park JY; Lee TY; Baik CS; Chai YG; Jung KH; Park KS; Roh W; Kim KS; Kim SH
    Neurosci Lett; 2010 Mar; 472(2):94-8. PubMed ID: 20117176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth kinetics and self-renewal of human mesenchymal stem cells derived from bone marrow of children with oncohematological diseases during expansion in vitro.
    Isaikina Y; Kustanovich A; Svirnovski A
    Exp Oncol; 2006 Jun; 28(2):146-51. PubMed ID: 16837907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of mesenchymal stem cells derived from bone marrow of children with oncohematological diseases on proliferation and self-renewal of hematopoietic progenitor cells in vitro.
    Isaikina Y; Shman T
    Exp Oncol; 2008 Jun; 30(2):121-8. PubMed ID: 18566575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased proliferation of human synovial mesenchymal stem cells with autologous human serum: comparisons with bone marrow mesenchymal stem cells and with fetal bovine serum.
    Nimura A; Muneta T; Koga H; Mochizuki T; Suzuki K; Makino H; Umezawa A; Sekiya I
    Arthritis Rheum; 2008 Feb; 58(2):501-10. PubMed ID: 18240254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic changes of adult porcine mesenchymal stem cells induced by prolonged passaging in culture.
    Vacanti V; Kong E; Suzuki G; Sato K; Canty JM; Lee T
    J Cell Physiol; 2005 Nov; 205(2):194-201. PubMed ID: 15880640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix-mediated retention of adipogenic differentiation potential by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion.
    Mauney JR; Volloch V; Kaplan DL
    Biomaterials; 2005 Nov; 26(31):6167-75. PubMed ID: 15913765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of different culture conditions for human mesenchymal stromal cells for clinical stem cell therapy.
    Haack-Sorensen M; Friis T; Bindslev L; Mortensen S; Johnsen HE; Kastrup J
    Scand J Clin Lab Invest; 2008; 68(3):192-203. PubMed ID: 17852829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation potential of bone marrow mesenchymal stem cells in duck.
    Li L; Bai X; Gong X; Liu H; Chen L; Guan W; Ma Y
    J Genet Genomics; 2009 Mar; 36(3):133-40. PubMed ID: 19302969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expansion of mesenchymal stem cells isolated from pediatric and adult donor bone marrow.
    Mareschi K; Ferrero I; Rustichelli D; Aschero S; Gammaitoni L; Aglietta M; Madon E; Fagioli F
    J Cell Biochem; 2006 Mar; 97(4):744-54. PubMed ID: 16229018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of ex vivo expansion culture conditions of mesenchymal stem cells for human cell therapy.
    Pérez-Ilzarbe M; Díez-Campelo M; Aranda P; Tabera S; Lopez T; del Cañizo C; Merino J; Moreno C; Andreu EJ; Prósper F; Pérez-Simón JA
    Transfusion; 2009 Sep; 49(9):1901-10. PubMed ID: 19497059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic and functional comparison of optimum culture conditions for upscaling of bone marrow-derived mesenchymal stem cells.
    Pal R; Hanwate M; Jan M; Totey S
    J Tissue Eng Regen Med; 2009 Mar; 3(3):163-74. PubMed ID: 19229888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and characterization of neurogenic mesenchymal stem cells in human scalp tissue.
    Shih DT; Lee DC; Chen SC; Tsai RY; Huang CT; Tsai CC; Shen EY; Chiu WT
    Stem Cells; 2005 Aug; 23(7):1012-20. PubMed ID: 15941858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis.
    Larghero J; Farge D; Braccini A; Lecourt S; Scherberich A; Foïs E; Verrecchia F; Daikeler T; Gluckman E; Tyndall A; Bocelli-Tyndall C
    Ann Rheum Dis; 2008 Apr; 67(4):443-9. PubMed ID: 17526552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adipose tissue-derived mesenchymal stem cells are more potent suppressors of dendritic cells differentiation compared to bone marrow-derived mesenchymal stem cells.
    Ivanova-Todorova E; Bochev I; Mourdjeva M; Dimitrov R; Bukarev D; Kyurkchiev S; Tivchev P; Altunkova I; Kyurkchiev DS
    Immunol Lett; 2009 Sep; 126(1-2):37-42. PubMed ID: 19647021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cell treatment in Amyotrophic Lateral Sclerosis.
    Mazzini L; Mareschi K; Ferrero I; Vassallo E; Oliveri G; Nasuelli N; Oggioni GD; Testa L; Fagioli F
    J Neurol Sci; 2008 Feb; 265(1-2):78-83. PubMed ID: 17582439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profile of cytokine and growth factor during differentiation of bone marrow-derived mesenchymal stem cell.
    Kim DH; Yoo KH; Choi KS; Choi J; Choi SY; Yang SE; Yang YS; Im HJ; Kim KH; Jung HL; Sung KW; Koo HH
    Cytokine; 2005 Jul; 31(2):119-26. PubMed ID: 15919213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies.
    Martin-Rendon E; Sweeney D; Lu F; Girdlestone J; Navarrete C; Watt SM
    Vox Sang; 2008 Aug; 95(2):137-48. PubMed ID: 18557828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow-derived mesenchymal stem cells: isolation, expansion, characterization, viral transduction, and production of conditioned medium.
    Gnecchi M; Melo LG
    Methods Mol Biol; 2009; 482():281-94. PubMed ID: 19089363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human gingiva-derived mesenchymal stem cells are superior to bone marrow-derived mesenchymal stem cells for cell therapy in regenerative medicine.
    Tomar GB; Srivastava RK; Gupta N; Barhanpurkar AP; Pote ST; Jhaveri HM; Mishra GC; Wani MR
    Biochem Biophys Res Commun; 2010 Mar; 393(3):377-83. PubMed ID: 20138833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis.
    Zheng ZH; Li XY; Ding J; Jia JF; Zhu P
    Rheumatology (Oxford); 2008 Jan; 47(1):22-30. PubMed ID: 18077486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.